FI113644B - Förfarande för framställning av terapeutiskt aktiva N-substituerade 3- azabicykloalkanderivat - Google Patents
Förfarande för framställning av terapeutiskt aktiva N-substituerade 3- azabicykloalkanderivatInfo
- Publication number
- FI113644B FI113644B FI962324A FI962324A FI113644B FI 113644 B FI113644 B FI 113644B FI 962324 A FI962324 A FI 962324A FI 962324 A FI962324 A FI 962324A FI 113644 B FI113644 B FI 113644B
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- substituted
- therapeutically active
- pct
- azabicycloalkane derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D497/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Ink Jet (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4341403A DE4341403A1 (de) | 1993-12-04 | 1993-12-04 | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
PCT/EP1994/003913 WO1995015327A1 (en) | 1993-12-04 | 1994-11-26 | N-substituted azabicycloalkane derivatives as neuroleptika asf |
Publications (3)
Publication Number | Publication Date |
---|---|
FI962324A0 FI962324A0 (sv) | 1996-06-03 |
FI962324A FI962324A (sv) | 1996-06-03 |
FI113644B true FI113644B (sv) | 2004-05-31 |
Family
ID=6504205
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI962324A FI113644B (sv) | 1993-12-04 | 1996-06-03 | Förfarande för framställning av terapeutiskt aktiva N-substituerade 3- azabicykloalkanderivat |
Country Status (13)
Country | Link |
---|---|
US (1) | US5703091A (sv) |
EP (1) | EP0731802B1 (sv) |
JP (1) | JP3935201B2 (sv) |
AT (1) | ATE194620T1 (sv) |
AU (1) | AU680583B2 (sv) |
BR (1) | BR9408246A (sv) |
DE (2) | DE4341403A1 (sv) |
ES (1) | ES2148476T3 (sv) |
FI (1) | FI113644B (sv) |
IL (1) | IL111861A (sv) |
NO (1) | NO306346B1 (sv) |
TW (1) | TW285667B (sv) |
WO (1) | WO1995015327A1 (sv) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19848521A1 (de) * | 1998-10-21 | 2000-04-27 | Basf Ag | Verfahren zur Herstellung von (+)-exo-6-Phenyl-3-azabicyclo-[3.2.0]heptanen |
DE19854147A1 (de) * | 1998-11-24 | 2000-05-25 | Basf Ag | Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht |
TWI244481B (en) | 1998-12-23 | 2005-12-01 | Pfizer | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
GB9912416D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912417D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912410D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912413D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912415D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
GB9912411D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
WO2001029000A2 (en) | 1999-10-15 | 2001-04-26 | Du Pont Pharmaceuticals Company | Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
US6784200B2 (en) * | 2000-10-13 | 2004-08-31 | Bristol-Myers Squibb Pharma Company | Bicyclic and tricyclic amines as modulators of chemokine receptor activity |
GB0015562D0 (en) * | 2000-06-23 | 2000-08-16 | Pfizer Ltd | Heterocycles |
SE0100326D0 (sv) | 2001-02-02 | 2001-02-02 | Astrazeneca Ab | New compounds |
MXPA03008109A (es) * | 2001-03-07 | 2003-12-12 | Pfizer Prod Inc | Moduladores de la actividad de receptores de quimiocinas. |
WO2004016604A2 (en) * | 2002-08-14 | 2004-02-26 | Abbott Laboratories | Azabicyclic compounds are central nervous system active agents |
EP1534675B1 (en) | 2002-08-23 | 2009-02-25 | Ranbaxy Laboratories, Ltd. | Fluoro and sulphonylamino containing 3,6-disubstituted azabicyclo¬3.1.0 hexane derivatives as muscarinic receptor antagonists |
EP1572648B1 (en) * | 2002-12-10 | 2008-07-09 | Ranbaxy Laboratories, Ltd. | 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists |
FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2005121145A2 (en) | 2004-06-09 | 2005-12-22 | F. Hoffmann-La Roche Ag | Octahydro-pyrrolo[3,4-c] derivatives and their use as antiviral compounds |
GB0507602D0 (en) | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
US7665658B2 (en) | 2005-06-07 | 2010-02-23 | First Data Corporation | Dynamic aggregation of payment transactions |
EP1849771A1 (en) * | 2006-04-28 | 2007-10-31 | Laboratorios Del Dr. Esteve, S.A. | Bicyclic tetrahydropyrrole compounds |
US8299113B2 (en) | 2006-04-28 | 2012-10-30 | Laboratorios Del Dr. Esteve, S.A. | Bicyclic tetrahydropyrrole compounds |
EP1849772A1 (en) * | 2006-04-28 | 2007-10-31 | Laboratorios Del Dr. Esteve, S.A. | Bicyclic tetrahydropyrrole compounds |
GB0625198D0 (en) * | 2006-12-18 | 2007-01-24 | Glaxo Group Ltd | Chemical compounds |
GB0809479D0 (en) * | 2008-05-23 | 2008-07-02 | Glaxo Group Ltd | Novel compounds |
US8598164B2 (en) | 2010-05-06 | 2013-12-03 | Vertex Pharmaceuticals Incorporated | Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels |
WO2012042539A2 (en) * | 2010-09-28 | 2012-04-05 | Panacea Biotec Ltd | Novel bicyclic compounds |
EP2642998B1 (en) | 2010-11-24 | 2020-09-16 | The Trustees of Columbia University in the City of New York | A non-retinoid rbp4 antagonist for treatment of age-related macular degeneration and stargardt disease |
SI2670752T1 (sl) | 2011-02-02 | 2016-10-28 | Vertex Pharmaceuticals Incorporated | Pirolopirazin-spirociklični piperidin amidi kot modulatorji ionskih kanalčkov |
EP2675812B1 (en) | 2011-02-18 | 2017-08-30 | Vertex Pharmaceuticals Incorporated | Chroman - spirocyclic piperidine amides as modulators of ion channels |
AU2012229187B2 (en) | 2011-03-14 | 2016-11-10 | Vertex Pharmaceuticals Incorporated | Morpholine-spirocyclic piperidine amides as modulators of ion channels |
WO2013166037A1 (en) | 2012-05-01 | 2013-11-07 | The Trustees Of Columbia University In The City Of New York | Non-retinoid antagonists for treatment of eye disorders |
WO2014152018A1 (en) * | 2013-03-14 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | Octahydrocyclopentapyrroles, their preparation and use |
EP2968304B1 (en) | 2013-03-14 | 2018-10-10 | The Trustees of Columbia University in the City of New York | 4-phenylpiperidines, their preparation and use |
WO2014151936A1 (en) | 2013-03-14 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | Octahydropyrrolopyrroles, their preparation and use |
US9938291B2 (en) | 2013-03-14 | 2018-04-10 | The Trustess Of Columbia University In The City Of New York | N-alkyl-2-phenoxyethanamines, their preparation and use |
WO2015048507A1 (en) * | 2013-09-26 | 2015-04-02 | Mnemosyne Pharmaceuticals, Inc. | Selective octahydro-cyclopenta[c] pyrrole negative modulators of nr2b |
SG11201608943VA (en) | 2014-04-30 | 2016-11-29 | Univ Columbia | Substituted 4-phenylpiperidines, their preparaiton and use |
JO3579B1 (ar) * | 2014-09-26 | 2020-07-05 | Luc Therapeutics Inc | مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول |
AU2016303558B2 (en) * | 2015-08-05 | 2020-08-06 | Indivior Uk Limited | Dopamine D3 receptor antagonists having a bicyclo moiety |
US10870660B2 (en) | 2016-07-28 | 2020-12-22 | Shionogi & Co., Ltd. | Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect |
EP3744721A4 (en) | 2018-01-26 | 2021-11-10 | Shionogi & Co., Ltd | CONDENSED CYCLIC COMPOUND WITH ANTAGONISM TO DOPAMINE D3 RECEPTOR |
WO2019152946A1 (en) | 2018-02-05 | 2019-08-08 | Alkermes, Inc. | Compounds for the treatment of pain |
CN114502540A (zh) | 2019-05-31 | 2022-05-13 | 医肯纳肿瘤学公司 | Tead抑制剂和其用途 |
MX2021014443A (es) | 2019-05-31 | 2022-01-06 | Ikena Oncology Inc | Inhibidores del dominio asociado mejorador de la transcripcion (tead) y usos de los mismos. |
CN114957087A (zh) * | 2022-04-13 | 2022-08-30 | 湖南复瑞生物医药技术有限责任公司 | 一种帕罗韦德中间体制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL110185C (sv) * | 1958-04-22 | |||
NO154582C (no) * | 1978-10-20 | 1986-11-05 | Ferrosan Ab | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider. |
US4435419A (en) * | 1981-07-01 | 1984-03-06 | American Cyanamid Company | Method of treating depression using azabicyclohexanes |
US4605655A (en) * | 1984-03-06 | 1986-08-12 | Bristol-Myers Company | Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives |
EP0190472B1 (en) * | 1984-12-21 | 1989-07-12 | Duphar International Research B.V | New pharmaceutical compositions having anti-psychotic properties |
US4994460A (en) * | 1989-06-01 | 1991-02-19 | Bristol-Myers Squibb Co. | Agents for treatment of brain ischemia |
US5055470A (en) * | 1989-06-01 | 1991-10-08 | Bristol-Myers Squibb Co. | Method of treatment of ischemia in brain |
DE4112353A1 (de) * | 1991-04-16 | 1992-10-22 | Basf Ag | 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung |
US5532243A (en) * | 1992-02-14 | 1996-07-02 | The Dupont Merck Pharmaceutical Company | Antipsychotic nitrogen-containing bicyclic compounds |
US5216018A (en) * | 1992-02-14 | 1993-06-01 | Du Pont Merck Pharmaceutical Company | Hydroisoindolines and hydroisoquinolines as psychotropic |
DE4219973A1 (de) * | 1992-06-19 | 1993-12-23 | Basf Ag | N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
DE4243287A1 (de) * | 1992-06-19 | 1993-12-23 | Basf Ag | N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung |
-
1993
- 1993-12-04 DE DE4341403A patent/DE4341403A1/de not_active Withdrawn
-
1994
- 1994-11-26 BR BR9408246A patent/BR9408246A/pt not_active Application Discontinuation
- 1994-11-26 JP JP51538295A patent/JP3935201B2/ja not_active Expired - Fee Related
- 1994-11-26 DE DE69425273T patent/DE69425273T2/de not_active Expired - Lifetime
- 1994-11-26 US US08/656,240 patent/US5703091A/en not_active Expired - Lifetime
- 1994-11-26 WO PCT/EP1994/003913 patent/WO1995015327A1/en active IP Right Grant
- 1994-11-26 ES ES95903284T patent/ES2148476T3/es not_active Expired - Lifetime
- 1994-11-26 AU AU12403/95A patent/AU680583B2/en not_active Ceased
- 1994-11-26 AT AT95903284T patent/ATE194620T1/de active
- 1994-11-26 EP EP95903284A patent/EP0731802B1/en not_active Expired - Lifetime
- 1994-12-02 IL IL11186194A patent/IL111861A/xx not_active IP Right Cessation
- 1994-12-05 TW TW083111264A patent/TW285667B/zh active
-
1996
- 1996-06-03 NO NO962286A patent/NO306346B1/no not_active IP Right Cessation
- 1996-06-03 FI FI962324A patent/FI113644B/sv not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO962286D0 (no) | 1996-06-03 |
NO306346B1 (no) | 1999-10-25 |
EP0731802A1 (en) | 1996-09-18 |
AU1240395A (en) | 1995-06-19 |
US5703091A (en) | 1997-12-30 |
FI962324A0 (sv) | 1996-06-03 |
NO962286L (no) | 1996-06-03 |
EP0731802B1 (en) | 2000-07-12 |
DE4341403A1 (de) | 1995-06-08 |
AU680583B2 (en) | 1997-07-31 |
DE69425273D1 (de) | 2000-08-17 |
JP3935201B2 (ja) | 2007-06-20 |
IL111861A0 (en) | 1995-03-15 |
DE69425273T2 (de) | 2001-01-18 |
TW285667B (sv) | 1996-09-11 |
ATE194620T1 (de) | 2000-07-15 |
ES2148476T3 (es) | 2000-10-16 |
FI962324A (sv) | 1996-06-03 |
BR9408246A (pt) | 1997-05-27 |
JPH09506346A (ja) | 1997-06-24 |
IL111861A (en) | 1999-08-17 |
WO1995015327A1 (en) | 1995-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI113644B (sv) | Förfarande för framställning av terapeutiskt aktiva N-substituerade 3- azabicykloalkanderivat | |
FI952607A (sv) | Farmakologiskt aktiva pyridinderivat och förfaranden för deras framställning | |
PL314188A1 (en) | Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions | |
AU2672995A (en) | {a}-annelated pyrrole derivatives and pharmaceutical uses thereof | |
AU4115396A (en) | 2,2-Dichloroalkane carboxylic acids, processes for their production and pharmaceutical agents containing these | |
NO306400B1 (no) | N-substituerte azabicykloheptan-derivater, anvendelse derav og farmasöytisk preparat | |
ES2094545T3 (es) | Derivados n-substituidos del 3-azabiciclo(3.2.0)heptano, como neurolepticos etc.. | |
HRP950437B1 (en) | N-substituted azabicycloheptane derivatives, their production and use | |
DK0805817T3 (da) | Thiolderivater med metallopeptidaseinhiberende aktivitet | |
ES2123796T3 (es) | Derivados de acidos fosfono-succinicos y su utilizacion como medicamentos. | |
AU3563495A (en) | Anthracycline derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |